33476465Friesen CS, Chan SS, Wagner JB, Hosey-Cojocari C, Csanaky IL, Shakhnovich VClinical and translational scienceEnd Stage Liver Disease; Non-alcoholic Fatty Liver Disease; Patient Selection; Pediatric ObesityAdult; Age Factors; Child; Clinical Trials as Topic; Disease Progression; HumansFriesen CS, Chan SS, Wagner JB, Hosey-Cojocari C, Csanaky IL, Shakhnovich V. Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective. Clin Transl Sci. 2021 05; 14(3):781-783.Clin Transl Sci2021-01-21T00:00:002021Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective.cmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD018450Physiology341050.966417Disease ProgressionD018579Concepts & IdeasProcedures21420.969676Patient SelectionMD, PhDSherwinChanSherwin S. Chan0.000000000000000.00000000000000109Chan, Sherwin0000-0002-2393-8355Vice Chair, Radiology 2Associate ProfessorRadiologyD058625Disorders220.998End Stage Liver DiseaseD063766Disorders291280.814798Pediatric ObesityD065626Disorders13240.958416Non-alcoholic Fatty Liver DiseasePediatricsClinicalD000328Living Beings11012590.736773AdultChildren's Mercy Kansas CityD000367Concepts & Ideas622150.934188Age FactorsDOJonathanWagnerJonathan B. Wagner0.000000000000000.00000000000000183Wagner, Jonathan0000000176906798Physician and Interim Division Director, Clinical Pharmacology, Toxicology & Therapeutic InnovationAuthorship 8364Authorship 8381Authorship 85002Authorship 854130.4012810.200644authors10.2510has subject areatrue1Physician and Interim Division Director, Clinical Pharmacology, Toxicology & Therapeutic InnovationPhysician and Interim Division Director, Clinical Pharmacology, Toxicology & Therapeutic Innovationtrue1Vice Chair, Radiology Vice Chair, Radiology D002648Living Beings11632570.520082ChildD002986Procedures23440.97686Clinical Trials as TopicD006801Living Beings12067970.397999Humans